biosimilar biological product

(3) The term “biosimilar biological product” means a specific strength of a biological product in final dosage form for which a biosimilar biological product application has been approved.

Source

21 USC § 379j-51(3)


Scoping language

None identified. Default scope is assumed to be the entire title.
Is this correct? or